Grifols S.A.(GRF.MC)— 技術面狀態
數據截至2026-10-12 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +1.8% vs the 50-day and +3.1% vs the 200-day average, 16.9% below the 52-week high and +19.7% off the 52-week low; a golden cross printed 17 sessions ago. Computed from daily closes.
移動平均線狀態
- 相對20日均線+3.8%
- 相對50日均線+1.8%
- 相對200日均線+3.1%
- 52週區間低於52週高點16.9% · 高於52週低點19.7%
- 連續走勢連續2個交易日上漲
- 均線交叉黃金交叉(17個交易日前)
- 50日均線交叉股價向上穿越50日均線(1個交易日前)
- 隨機指標%K 93.5 · %D 75.9(黃金交叉)
相關頁面: GRF.MC圖表與概覽 · 品質與財務體檢 · 訊號看板
FAQ · from the current data · as of 2026-10-12
Quick answers
GRF.MC目前的Closelook訊號是什麼?
Bullish stack, 200-day still turning — Trades +1.8% vs the 50-day and +3.1% vs the 200-day average, 16.9% below the 52-week high and +19.7% off the 52-week low; a golden cross printed 17 sessions ago. Computed from daily closes.(截至2026-10-12;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
GRF.MC目前是否位於50日與200日均線上方?
截至2026-10-12,Grifols S.A.位於50日均線上方(+1.8%),200日均線上方(+3.1%);距20日均線+3.8%。
GRF.MC距52週高點有多遠?
截至2026-10-12,低於52週高點16.9%,高於52週低點19.7%。
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- NVO Novo Nordisk A/Sindustry
- GSK GlaxoSmithKline PLC ADRindustry
- ABBV AbbVie Incindustry
- BIIB Biogen Incindustry
- GILD Gilead Sciences Incindustry
- PFE Pfizer Incindustry
- MRK Merck & Company Incindustry
- AMGN Amgen Incindustry
- OGN Organon & Coindustry
- JNJ Johnson & Johnsonindustry
- SNY Sanofi ADRindustry
- BMY Bristol-Myers Squibb Companyindustry
- AZN AstraZeneca PLCindustry
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- ALM.MC Almirall S.A.sector
- HALO Halozyme Therapeutics Incsector